Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type-1 Diabetes Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Rapid-Acting Insulin
1.2.3 Short-Acting Insulin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Type-1 Diabetes Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals & Clinics
1.3.3 Academic & Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Type-1 Diabetes Treatment Market Perspective (2018-2033)
2.2 Type-1 Diabetes Treatment Growth Trends by Region
2.2.1 Global Type-1 Diabetes Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Type-1 Diabetes Treatment Historic Market Size by Region (2018-2023)
2.2.3 Type-1 Diabetes Treatment Forecasted Market Size by Region (2024-2033)
2.3 Type-1 Diabetes Treatment Market Dynamics
2.3.1 Type-1 Diabetes Treatment Industry Trends
2.3.2 Type-1 Diabetes Treatment Market Drivers
2.3.3 Type-1 Diabetes Treatment Market Challenges
2.3.4 Type-1 Diabetes Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Type-1 Diabetes Treatment Players by Revenue
3.1.1 Global Top Type-1 Diabetes Treatment Players by Revenue (2018-2023)
3.1.2 Global Type-1 Diabetes Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Type-1 Diabetes Treatment Revenue
3.4 Global Type-1 Diabetes Treatment Market Concentration Ratio
3.4.1 Global Type-1 Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type-1 Diabetes Treatment Revenue in 2022
3.5 Type-1 Diabetes Treatment Key Players Head office and Area Served
3.6 Key Players Type-1 Diabetes Treatment Product Solution and Service
3.7 Date of Enter into Type-1 Diabetes Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Type-1 Diabetes Treatment Breakdown Data by Type
4.1 Global Type-1 Diabetes Treatment Historic Market Size by Type (2018-2023)
4.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2024-2033)
5 Type-1 Diabetes Treatment Breakdown Data by Application
5.1 Global Type-1 Diabetes Treatment Historic Market Size by Application (2018-2023)
5.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Type-1 Diabetes Treatment Market Size (2018-2033)
6.2 North America Type-1 Diabetes Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Type-1 Diabetes Treatment Market Size by Country (2018-2023)
6.4 North America Type-1 Diabetes Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Type-1 Diabetes Treatment Market Size (2018-2033)
7.2 Europe Type-1 Diabetes Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Type-1 Diabetes Treatment Market Size by Country (2018-2023)
7.4 Europe Type-1 Diabetes Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Type-1 Diabetes Treatment Market Size (2018-2033)
8.2 Asia-Pacific Type-1 Diabetes Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Type-1 Diabetes Treatment Market Size (2018-2033)
9.2 Latin America Type-1 Diabetes Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Type-1 Diabetes Treatment Market Size by Country (2018-2023)
9.4 Latin America Type-1 Diabetes Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Type-1 Diabetes Treatment Market Size (2018-2033)
10.2 Middle East & Africa Type-1 Diabetes Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Detail
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Type-1 Diabetes Treatment Introduction
11.1.4 Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.1.5 Astellas Pharma Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Type-1 Diabetes Treatment Introduction
11.2.4 Merck Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Type-1 Diabetes Treatment Introduction
11.3.4 Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.3.5 Eli Lilly Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Detail
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Type-1 Diabetes Treatment Introduction
11.4.4 Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.4.5 Novo Nordisk Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Type-1 Diabetes Treatment Introduction
11.5.4 Sanofi Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.5.5 Sanofi Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Type-1 Diabetes Treatment Introduction
11.6.4 AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Boehringer Ingelheim GmbH
11.7.1 Boehringer Ingelheim GmbH Company Detail
11.7.2 Boehringer Ingelheim GmbH Business Overview
11.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Introduction
11.7.4 Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.7.5 Boehringer Ingelheim GmbH Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Type-1 Diabetes Treatment Introduction
11.8.4 Novartis Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Detail
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Type-1 Diabetes Treatment Introduction
11.9.4 Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.9.5 Pfizer Inc. Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Detail
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Type-1 Diabetes Treatment Introduction
11.10.4 Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.10.5 Abbott Laboratories Recent Development
11.11 Mannkind Corporation
11.11.1 Mannkind Corporation Company Detail
11.11.2 Mannkind Corporation Business Overview
11.11.3 Mannkind Corporation Type-1 Diabetes Treatment Introduction
11.11.4 Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.11.5 Mannkind Corporation Recent Development
11.12 Braun Melsungen AG
11.12.1 Braun Melsungen AG Company Detail
11.12.2 Braun Melsungen AG Business Overview
11.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Introduction
11.12.4 Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.12.5 Braun Melsungen AG Recent Development
11.13 Macrogenics, Inc.
11.13.1 Macrogenics, Inc. Company Detail
11.13.2 Macrogenics, Inc. Business Overview
11.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Introduction
11.13.4 Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.13.5 Macrogenics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Type-1 Diabetes Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Rapid-Acting Insulin
Table 3. Key Players of Short-Acting Insulin
Table 4. Key Players of Others
Table 5. Global Type-1 Diabetes Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Type-1 Diabetes Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Type-1 Diabetes Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Type-1 Diabetes Treatment Market Share by Region (2018-2023)
Table 9. Global Type-1 Diabetes Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Type-1 Diabetes Treatment Market Share by Region (2024-2033)
Table 11. Type-1 Diabetes Treatment Market Trends
Table 12. Type-1 Diabetes Treatment Market Drivers
Table 13. Type-1 Diabetes Treatment Market Challenges
Table 14. Type-1 Diabetes Treatment Market Restraints
Table 15. Global Type-1 Diabetes Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Type-1 Diabetes Treatment Market Share by Players (2018-2023)
Table 17. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2022)
Table 18. Ranking of Global Top Type-1 Diabetes Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Type-1 Diabetes Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Type-1 Diabetes Treatment Product Solution and Service
Table 22. Date of Enter into Type-1 Diabetes Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Type-1 Diabetes Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2024-2033)
Table 28. Global Type-1 Diabetes Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Type-1 Diabetes Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Type-1 Diabetes Treatment Revenue Market Share by Application (2024-2033)
Table 32. North America Type-1 Diabetes Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Type-1 Diabetes Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Type-1 Diabetes Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Type-1 Diabetes Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Type-1 Diabetes Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Type-1 Diabetes Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Type-1 Diabetes Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Type-1 Diabetes Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Type-1 Diabetes Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Type-1 Diabetes Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Type-1 Diabetes Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. Astellas Pharma Company Detail
Table 48. Astellas Pharma Business Overview
Table 49. Astellas Pharma Type-1 Diabetes Treatment Product
Table 50. Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 51. Astellas Pharma Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck Type-1 Diabetes Treatment Product
Table 55. Merck Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 56. Merck Recent Development
Table 57. Eli Lilly Company Detail
Table 58. Eli Lilly Business Overview
Table 59. Eli Lilly Type-1 Diabetes Treatment Product
Table 60. Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 61. Eli Lilly Recent Development
Table 62. Novo Nordisk Company Detail
Table 63. Novo Nordisk Business Overview
Table 64. Novo Nordisk Type-1 Diabetes Treatment Product
Table 65. Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 66. Novo Nordisk Recent Development
Table 67. Sanofi Company Detail
Table 68. Sanofi Business Overview
Table 69. Sanofi Type-1 Diabetes Treatment Product
Table 70. Sanofi Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. AstraZeneca Company Detail
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Type-1 Diabetes Treatment Product
Table 75. AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Boehringer Ingelheim GmbH Company Detail
Table 78. Boehringer Ingelheim GmbH Business Overview
Table 79. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product
Table 80. Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 81. Boehringer Ingelheim GmbH Recent Development
Table 82. Novartis Company Detail
Table 83. Novartis Business Overview
Table 84. Novartis Type-1 Diabetes Treatment Product
Table 85. Novartis Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Pfizer Inc. Company Detail
Table 88. Pfizer Inc. Business Overview
Table 89. Pfizer Inc. Type-1 Diabetes Treatment Product
Table 90. Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 91. Pfizer Inc. Recent Development
Table 92. Abbott Laboratories Company Detail
Table 93. Abbott Laboratories Business Overview
Table 94. Abbott Laboratories Type-1 Diabetes Treatment Product
Table 95. Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 96. Abbott Laboratories Recent Development
Table 97. Mannkind Corporation Company Detail
Table 98. Mannkind Corporation Business Overview
Table 99. Mannkind Corporation Type-1 Diabetes Treatment Product
Table 100. Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 101. Mannkind Corporation Recent Development
Table 102. Braun Melsungen AG Company Detail
Table 103. Braun Melsungen AG Business Overview
Table 104. Braun Melsungen AG Type-1 Diabetes Treatment Product
Table 105. Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 106. Braun Melsungen AG Recent Development
Table 107. Macrogenics, Inc. Company Detail
Table 108. Macrogenics, Inc. Business Overview
Table 109. Macrogenics, Inc. Type-1 Diabetes Treatment Product
Table 110. Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 111. Macrogenics, Inc. Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Type-1 Diabetes Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Type-1 Diabetes Treatment Market Share by Type: 2022 VS 2033
Figure 3. Rapid-Acting Insulin Features
Figure 4. Short-Acting Insulin Features
Figure 5. Others Features
Figure 6. Global Type-1 Diabetes Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Type-1 Diabetes Treatment Market Share by Application: 2022 VS 2033
Figure 8. Hospitals & Clinics Case Studies
Figure 9. Academic & Research Institutes Case Studies
Figure 10. Type-1 Diabetes Treatment Report Years Considered
Figure 11. Global Type-1 Diabetes Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Type-1 Diabetes Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Type-1 Diabetes Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Type-1 Diabetes Treatment Market Share by Players in 2022
Figure 15. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Type-1 Diabetes Treatment Revenue in 2022
Figure 17. North America Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Type-1 Diabetes Treatment Market Share by Country (2018-2033)
Figure 19. United States Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Type-1 Diabetes Treatment Market Share by Country (2018-2033)
Figure 23. Germany Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Type-1 Diabetes Treatment Market Share by Region (2018-2033)
Figure 31. China Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Type-1 Diabetes Treatment Market Share by Country (2018-2033)
Figure 39. Mexico Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Type-1 Diabetes Treatment Market Share by Country (2018-2033)
Figure 43. Turkey Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Type-1 Diabetes Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Astellas Pharma Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 46. Merck Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 47. Eli Lilly Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 48. Novo Nordisk Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 49. Sanofi Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 50. AstraZeneca Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 51. Boehringer Ingelheim GmbH Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 53. Pfizer Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 54. Abbott Laboratories Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 55. Mannkind Corporation Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 56. Braun Melsungen AG Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 57. Macrogenics, Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed